Navigation Links
Simcere Pharmaceutical Group to Announce Second Quarter 2012 Financial Results on Friday, August 10, 2012
Date:7/30/2012

NANJING, China, July 30, 2012 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2012 on Friday, August 10, 2012, before the market opens in the United States. Simcere's management will host an earnings conference call on the same day at 8 a.m. ET (Friday, August 10, at 8 p.m. Beijing/Hong Kong time).

To access the conference call, please dial:International toll:

+65.6723.9381United States toll-free:

+1.866.519.4004United States toll:

+1.718.354.1231China Domestic toll:

800.819.0121 China Domestic mobile toll:

400.620.8038 Hong Kong toll:

+852.2475.0994Please ask to be connected to Q2 2012 Simcere Pharmaceutical Group Earnings Conference Call and provide the following passcode: 15292591. Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's web site at www.simcere.com.

Following the earnings conference call, an archive of the call will be available by dialing:United States toll-free:

+1.866.214.5335United States toll:

+1.718.354.1232The passcode for replay participants is 15292591. The telephone replay also will be archived on the "Investor Relations" section of the company's website for seven days following the earnings announcement.

About Simcere Pharmaceutical GroupSimcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere co
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
2. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
3. Pharmaceutical Manufacturers Attempt to Safeguard Business Continuity from Potential Threats and Disasters to Production
4. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
5. Jason Pharmaceuticals, Inc. Reaches Proposed Consent Agreement with FTC
6. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2012 Financial Results On August 2, 2012
7. GDS Internationals Fourth Next Generation Pharmaceutical Drug Development Summit Attracts an Unprecedented Delegation of Thought Leaders
8. ADVENTRX Pharmaceuticals to Present at 1st Annual Sickle Cell Disease Therapeutics Conference
9. Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.
10. Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
11. Avion Pharmaceuticals, LLC., Launches Prenate Mini
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Company, Inc. (NYSE: LCI ) today reported financial ... 31, 2015.  For the fiscal 2015 ... from $80.0 million in last year,s third quarter.  Gross ... net sales, from $56.1 million, or 70% of net ... million from $10.6 million for the fiscal 2014 third ...
(Date:5/6/2015)... 2015 CVS Health (NYSE: CVS ) officially announced ... locations that sustained heavy fire damage during protests last week.  ... Baltimore over the past week or so, our hearts ... CVS Health President and CEO Larry Merlo . "Our purpose ... health. There is no better way that we can fulfill that ...
(Date:5/6/2015)... Del. , May 6, 2015  Rigrodsky & Long, P.A.: ... Aerie Pharmaceuticals, Inc. (NASDAQ GM: AERI )? , Did ... 2015, inclusive? , Did you lose money in your investment ... your rights? Rigrodsky & Long, P.A. ... MacFall , announces that a complaint has been filed in the ...
Breaking Medicine Technology:Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 2Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 3Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 4Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 6Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 8CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3
... Pharmaceuticals Inc. announced a plan to provide VX-770, a CF medicine ... critical medical need and may benefit from treatment prior to potential ... (FDA). Pending FDA review and approval, Vertex expects ... as early as July. "We are delighted that ...
... from new post hoc analyses assessing the effects of ... and utilizing novel surrogate markers suggested improved daytime functioning ... and depressive symptoms in patients with moderate to severe ... Congress of Parkinson,s disease and Movement disorders in Toronto, ...
Cached Medicine Technology:Vertex Plans to Provide Access to Potential CF Therapy VX-770 for Patients with Critical Medical Need 2New Post Hoc Analyses Examined the Effects of Neupro® (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in Restless Legs Syndrome 2New Post Hoc Analyses Examined the Effects of Neupro® (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in Restless Legs Syndrome 3New Post Hoc Analyses Examined the Effects of Neupro® (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in Restless Legs Syndrome 4New Post Hoc Analyses Examined the Effects of Neupro® (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in Restless Legs Syndrome 5New Post Hoc Analyses Examined the Effects of Neupro® (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in Restless Legs Syndrome 6New Post Hoc Analyses Examined the Effects of Neupro® (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in Restless Legs Syndrome 7
(Date:5/6/2015)... MD (PRWEB) May 06, 2015 The Canton ... Baltimore Ravens for the 6th annual charity softball game. ... at M & T Bank Stadium. Past years guests include ... others. Tickets are still on sale if you ... advocating for local non-profit organizations, such as SOAR Baltimore ...
(Date:5/6/2015)... Jacksonville, Fla. (PRWEB) May 06, 2015 ... Orthopaedic Institute are the first in north Florida ... This technology is the latest innovation in total ... a highly advanced, surgeon-controlled robotic arm that enables ... Baptist Medical Center Jacksonville has offered MAKOplasty® partial ...
(Date:5/6/2015)... 2015 TMG Health, the leading national ... Advantage, Medicare Part D and Managed Medicaid markets, was ... Team category at the BCI North America Awards, a ... the outstanding contribution of business continuity professionals and organizations ... including the USA and Canada. The North America Awards ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as ... latest and coolest applications on the market for iOS, Android, and ... the app review and shared with viewers how this application walks ... to be a good navigator people had to know how to ... is a master navigator. Well what if people could “GPS” their ...
(Date:5/6/2015)... Angeles (PRWEB) May 06, 2015 ... the #1 ranked international water, sanitation and hygiene nonprofit ... for communities across the world and it brings our ... Carnett, CEO of Marketing Maven. “The ongoing relationship between ... opportunities available for people to learn about and support ...
Breaking Medicine News(10 mins):Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3
... lifestyle habits relate to the risk of certain cancers (e.g., ... authors estimate the proportion of cancer in the population associated ... find that smoking has, by far, the largest effect on ... the UK attributable to tobacco use. A poor diet ...
... hold churches and pharmaceutical companies to different moral standards ... the Journal of Consumer Research . ... that he is in the business of maximizing shareholder ... his company,s offeringsand those prices should be very high ...
... Professor of Surgery at Thomas Jefferson University and ... Cancers Center , and Mon-Li Chu, Ph.D., Professor ... Cutaneous Biology , were awarded $200,000 from the University ... for their breakthrough work on a diagnostic test ...
... - telling these smells apart is no problem for the ... has been uncovered by an interdisciplinary team of researchers at ... on the dynamics of the three-dimensional structure of the binding ... found a characteristic pattern of hydrogen bonds between odorant and ...
... DETROIT Hitching a ride into the retina on ... age-related macular degeneration and retinitis pigmentosa. A collaborative research ... Clinic and Johns Hopkins Medicine shows that steroids attached ... neuroinflammation, leaving the rest of the eye unaffected and ...
... Adding a drug that activates genes to frontline combination therapy ... rate after initial treatment, researchers at The University of Texas ... of the American Society of Hematology. Results of the ... for a national Phase III clinical trial of the new ...
Cached Medicine News:Health News:Commercial or communal: Why is outsourcing taboo for churches and pharmaceutical companies? 2Health News:Thomas Jefferson University receives Science Center's QED Award for pancreatic cancer research 2Health News:Thomas Jefferson University receives Science Center's QED Award for pancreatic cancer research 3Health News:A good nose: RUB-Researchers decipher interaction of fragrances and olfactory receptors 2Health News:Nanoparticles help researchers deliver steroids to retina 2Health News:AML patients have high response rate with vorinostat added to treatment 2
... Size: 3.0 x 7.5 x ... Scleral Sponge II line designed by ... material is a closed cell sponge ... are soft with rounded edges to ...
... x 80 mm. Storz offers the ... by Harvey A. Lincoff, M.D. ... sponge which is non-toxic and non-antigenic. ... to minimize scleral intrusion. These implants ...
Thin silicone pad implant. Indications: For closing scleral ruptures. Overall length: 7.8 mm....
... mm. Half oval. The original Scleral Sponge II ... been modified by Dr. Joseph Olk with this ... cell sponge which is non-toxic and non-antigenic. Implants ... intrusion. These implants are packaged sterile and sold ...
Medicine Products: